BRCA2 c.7435+5T>G
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal. | ||
| Splicing | ||
| Splice region | donor +5 | donor splice region (+5, within the first 6 intronic nt) · inside the BP7-excluded zone |
|---|---|---|
| SpliceAI | Δ0.36 | donor gain at this position · raw score · deltas |
| Constraint at this position | ||
| Conservation | phyloP -0.24 | GERP -1.8 |
| Non-coding constraint | Z 0.31 | 1 kb window · o/e 0.97 · regional · uncalibrated |
| Overall | ||
| CADD | 21.1 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,472 |
| European (non-Finnish)grpmax | 0.000254% | 393,244 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BRCA2
- Coding
- c.7435+5T>G
- MANE Select
- NM_000059
- dbSNP
- rs775973095
- Type
- single nucleotide variant
- Location
- chr13:32355293 (GRCh38)
- Gene constraint
- LOEUF 0.803 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
Disease context
hereditary breast ovarian cancer syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: breast-ovarian cancer, familial, susceptibility to, 2hereditary neoplastic syndrome
For Hereditary breast and/or ovarian cancer syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult, Elderly
Similar variants
- BRCA2 c.316+1G>T Pathogenic ★★★ same condition
- BRCA2 c.316+2T>C Pathogenic ★★★ same condition
- BRCA2 c.316+5G>A Pathogenic ★★★ same condition
- BRCA2 c.316+5G>C Pathogenic ★★★ same condition
- BRCA2 c.475+1G>A Pathogenic ★★★ same condition
- BRCA2 c.475+1G>T Pathogenic ★★★ same condition
- BRCA2 c.476-2A>G Pathogenic ★★★ same condition
- BRCA2 c.517-2A>G Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brca2-c-7435-plus-5t-g (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown